Delivery Order SPE2DB20D2104-SPE2DB24FV20F

Award Date 7/16/24
Potential Completion Date 8/6/24
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,165.34 firm fixed-price delivery order is for the supply of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty medication. The contract has an ultimate completion date of April 15, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,889.56 firm fixed-price delivery order is for the supply of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty pharmaceutical product. The contract has an ultimate completion date of December 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,082.67 Firm Fixed Price Delivery Order contract is for the supply of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty medication. The contract has an ultimate completion date of April 9, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,987.78 firm fixed-price delivery order is for the supply of BENLYSTA 200 MG/ML AUTOINJECTML, a medication. The contract has an ultimate completion date of June 6, 2025 and does not utilize a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BENLYSTA 200 MG/ML AUTOINJECTML. The $5,779.12 firm fixed-price delivery order contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of BENLYSTA 200 MG/ML AUTOINJECTOR to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $8,379.09, has a period of performance through December 2024. Amerisourcebergen holds a Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999 through November 2026. This IDC serves as the primary vehicle for providing a broad...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,586.06 Delivery Order contract is for the supply of BENLYSTA 200 MG/ML AUTOINJECTOR, a specialty medication. The contract has a firm fixed price pricing type and a completion date of November 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,889.56 firm fixed-price delivery order is for the supply of Benlysta 200 mg/mL autoinjector medication. The contract has an ultimate completion date of December 12, 2024 and was awarded on November 20, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA). The $2,793.03 firm fixed-price delivery order is for the supply of the pharmaceutical product BENLYSTA 200 MG/ML AUTOINJECTML. The contract has an ultimate completion date of December 5, 2024 and was awarded on November 13, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a $11,172.12 Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty pharmaceutical product. The contract, with a completion date of October 29, 2024, is not associated with any set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by DLA and other federal...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FV20F
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,793.03 delivery order is for the supply of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty medication. The contract has an ultimate completion date of August 6, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract was not designated with a set-aside requirement, indicating open competition.

Generated 2/27/25, 12:48 PM